Steady dose escalation to higher doses than for glycaemic control are indicated if: BMI is 30 kg/m 2 , or BMI 27 to 30 kg/m 2 , and for the range 2730 kg/m 2 if there is one weight-related comorbidity (hypertension, dyslipidaemia, cardiovascular disease, obstructive sleep apnoea, prediabetes or T2D
BPC-157 Gut & soft-tissue repair What it helps with: gut healing, reducing inflammation, and faster repair of muscle/tendon/ligament injuries
Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population
Gala GLP-1 connects patients with licensed healthcare providers who independently evaluate eligibility for treatment
C., Yamao-Harigaya, W., Iwatsubo, T